These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 37847055

  • 1. Three molecular subtypes and a five-gene signature for hepatocellular carcinoma based on m7G-related classification.
    Yue Y, Tao J, An D, Shi L.
    J Gene Med; 2024 Jan; 26(1):e3611. PubMed ID: 37847055
    [Abstract] [Full Text] [Related]

  • 2. Construction of m7G RNA modification-related prognostic model and prediction of immune therapy response in hepatocellular carcinoma.
    Wang H, Shui X, Zhang Z, He M, Tai S, Lin Y.
    Transl Cancer Res; 2024 Jun 30; 13(6):2799-2811. PubMed ID: 38988942
    [Abstract] [Full Text] [Related]

  • 3. Novel Molecular Subtyping Scheme Based on In Silico Analysis of Cuproptosis Regulator Gene Patterns Optimizes Survival Prediction and Treatment of Hepatocellular Carcinoma.
    Jiang H, Chen H, Wang Y, Qian Y.
    J Clin Med; 2023 Sep 05; 12(18):. PubMed ID: 37762710
    [Abstract] [Full Text] [Related]

  • 4. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.
    Liu P, Dong C, Shi H, Yan Z, Zhang J, Liu J.
    J Gastrointest Oncol; 2022 Dec 05; 13(6):3169-3182. PubMed ID: 36636051
    [Abstract] [Full Text] [Related]

  • 5. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
    Gao S, Zhang L, Wang H.
    Funct Integr Genomics; 2023 Aug 04; 23(3):262. PubMed ID: 37540264
    [Abstract] [Full Text] [Related]

  • 6. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X, Guo J, Chen G, Fang C, Hu L, Li J, Zhang C.
    J Immunol Res; 2022 Aug 04; 2022():3393027. PubMed ID: 36438201
    [Abstract] [Full Text] [Related]

  • 7. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification.
    Yang C, Zhang L, Hao X, Tang M, Zhou B, Hou J.
    Curr Oncol; 2022 Dec 28; 30(1):430-448. PubMed ID: 36661684
    [Abstract] [Full Text] [Related]

  • 8. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs.
    Dai YY, Gao YP, Chen LX, Liu JS, Zeng C, Zhou JD, Wu HL.
    Front Genet; 2022 Dec 28; 13():930446. PubMed ID: 36110218
    [Abstract] [Full Text] [Related]

  • 9. Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma.
    Zhou Y, Li X, Long G, Tao Y, Zhou L, Tang J.
    Front Immunol; 2022 Dec 28; 13():994259. PubMed ID: 36341373
    [Abstract] [Full Text] [Related]

  • 10. Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma.
    Peng YL, Dong YF, Guo LL, Li MY, Liao H, Li RS.
    PLoS One; 2023 Dec 28; 18(8):e0289552. PubMed ID: 37535570
    [Abstract] [Full Text] [Related]

  • 11. Establishment of a new molecular subtyping and prognostic signature with m6A/m5C/m1A/m7G regulatory genes for hepatocellular carcinoma.
    Liu T, Wang Y, Li Z, Sun L, Yang K, Chen J, Han X, Qi L, Zhou X, Wang P.
    Heliyon; 2023 Nov 28; 9(11):e21285. PubMed ID: 38027812
    [Abstract] [Full Text] [Related]

  • 12. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation.
    Wang T, Zhou Z, Wang X, You L, Li W, Zheng C, Zhang J, Wang L, Kong X, Gao Y, Sun X.
    Front Genet; 2022 Nov 28; 13():929035. PubMed ID: 36081998
    [Abstract] [Full Text] [Related]

  • 13. Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma.
    Zhu J, Huang Q, Peng X, Luo C, Liu Z, Liu D, Yuan H, Yuan R, Cheng X.
    Front Immunol; 2023 Nov 28; 14():1218661. PubMed ID: 37662906
    [Abstract] [Full Text] [Related]

  • 14. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S, Li J, Shen J, Zhao Y, Wu X, Li M, Yang X, Kaboli PJ, Du F, Zheng Y, Wen Q, Cho CH, Yi T, Xiao Z.
    Front Immunol; 2021 Nov 28; 12():653836. PubMed ID: 33897701
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma.
    Li Y, Zhao K, Wu R, Wang J, Wang Q, Xiong Q, Xie F, Lei H, Feng P.
    J Gastrointest Oncol; 2023 Jun 30; 14(3):1392-1411. PubMed ID: 37435203
    [Abstract] [Full Text] [Related]

  • 17. An independent poor-prognosis subtype of hepatocellular carcinoma based on the tumor microenvironment.
    Wang J, Lou J, Fu L, Jin Q.
    J Int Med Res; 2021 Feb 30; 49(2):300060520980646. PubMed ID: 33567957
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
    Luo Y, Liu H, Fu H, Ding GS, Teng F.
    Front Immunol; 2022 Feb 30; 13():974377. PubMed ID: 36458010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.